Table Of ContentAntiviral Research, 19 (1992) 363-365
Author Index
Adler, R., see Almog, Y. (19) 285 2'-nor-cGMP and ganciclovir against cytome-
Almog, Y., Klein, A., Adler, R., Laub, O., Tur- galovirus infection in a guinea pig model (19)
Kaspa, R., Estrogen suppresses hepatitis B virus 193
expression in male athymic mice transplanted Field, H.J., see Gibson, J.S. (19) 219
with HBV transfected Hep G-2 cells (19) 285 Fisher-Hoch, S.P., Gborie, S., Parker, L., Huggins,
Amici, C., Palamara, A.T., Garaci, E., Santoro, J., Unexpected adverse reactions during a
M.G., Inhibition of Sendai virus replication by clinical trial in rural West Africa (19) 139
A'?-prostaglandin J,: induction of heat shock Furneri, P.M., see Pinizzotto, M.R. (19) 29
protein synthesis and alteration of protein
glycosylation (19) 129 Garaci, E., see Amici, C. (19) 129
Arnold, K., see Herrmann, A. (19) 295 Garozzo, A., see Pinizzotto, M.R. (19) 29
Ayehunie, S., see Wondimu, Z. (19) 353 Gborie, S., see Fisher-Hoch, S.P. (19) 139
Geremia, E., see Pinizzotto, M.R. (19) 29
Baldanti, F., see Gerna, G. (19) 333 Gerin, J.L., see Korba, B.E. (19) 55
Beenhouwer, D.O., Rankin, J.A., Mellors, J.W., Gerna, G., Baldanti, F., Zavattoni, M., Sarasini,
Anti-HIV activity of 3’-azido-3’-deoxythymidine A., Percivalle, E., Revello, M.G., Monitoring of
(AZT) in primary mononuclear phagocytes (19) ganciclovir sensitivity of multiple human cyto-
43 megalovirus strains coinfecting blood of an
Beilharz, M.W., see Swaminathan, N. (19) 149 AIDS patient by an immediate-early antigen
Benaissa-Trouw, B.J., see Kraaijeveld, C.A. (19) plaque assay (19) 333
275 Gibson, J.S., Slater, J.D., Field, H.J., The activity
Berk, L., Schalm, S.W., Heijtink, R.A., Zidovudine of (S)-1-[3-hydroxy-2-phosphonyl methoxy)
inhibits hepatitis B virus replication (19) 111 propyl] cytosine (HPMPC) against equine
Blakeslee Jr, J.R., see Tanabe-Tochikura, A. (19) herpesvirus-1 (EHV-1) in cell cultures, mice
161 and horses (19) 219
Borchardt, R.T., see Liu, S. (19) 247 Guerrera, F., see Pinizzotto, M.R. (19) 29
Boyer, S.J., see Swaminathan, N. (19) 149
Britton, S., see Wondimu, Z. (19) 353 Heijtink, R.A., see Berk, L. (19) 111
Burger, R.A., see Sidwell, R.W. (19) 313 Herdewijn, P.A.M.M., Novel nucleoside strategies
Burger, R.A., see Warren, R.P. (19) 233 for anti-HIV and anti-HSV therapy (19) |
Burns, P., see Chatterjee, S. (19) 181 Herrmann, A., Korte, T., Arnold, K., Hillebrecht,
B., The influence of dextran sulfate on influenza
Castro, A., see Pinizzotto, M.R. (19) 29 A virus fusion with erythrocyte membranes (19)
Chang, C.-C., Lin, C.-N., Lin, J.-Y., Inhibition of 295
Moloney murine leukemia virus reverse tran- Hillebrecht, B., see Herrmann, A. (19) 295
scriptase activity by tetrahydroxyxanthones Hitchcock, M.J.M., see Starrett Jr, J.E. (19) 267
isolated from the Chinese herb, Tripterosper- Hitchcock, M., see Sidwell, R.W. (19) 313
mum laceolatum (Hyata) (19) 119 Hsiung, G.D., see Feng, J.S. (19) 193
Chatterjee, S., Burns, P., Whitley, R.J., Kern, E.R., Huggins, J., see Fisher-Hoch, S.P. (19) 139
Effect of (S)-1-[(3-hydroxy-2-phosphonyl meth-
oxy) propyl] cytosine on the replication and Karlsson, A., see Olofsson, S. (19) 71
morphogenesis of herpes simplex virus type 1 Kern, E.R., see Chatterjee, S. (19) 181
(19) 181 Kern, E.R., see Renau, T.E. (19) 15
Crouch, J.Y., see Feng, J.S. (19) 193 Klein, A., see Almog, Y. (19) 285
Klinken, S.P., see Swaminathan, N. (19) 149
Drach, J.C., see Renau, T.E. (19) 15 Koch, J.A., Ruprecht, R.M., Animal models for
anti-AIDS therapy (Mini-review) (19) 81
Ekstijn, G.L., see Kraaijeveld, C.A. (19) 275 Korba, B.E., Gerin, J.L., Use of a standardized cell
Eriksson, S., see Olofsson, S. (19) 71 culture assay to assess activities of nucleoside
analogs against hepatitis B virus replication (19)
Feng, J.S., Crouch, J.Y., Tolman, R.L., Lucia, 55
H.L., Hsiung, G.D., Combined treatment with Korte, T., see Herrmann, A. (19) 295
364
Kraaijeveld, C.A., Oosterlaken, T.A.M., Snijders, Castro, A., La Rosa, M.G., Furneri, P.M.,
A., Benaissa-Trouw, B.J., Ekstijn, G.L., Snippe, Geremia, E., In vitro antiviral activity of four
H., A vaccine against Semliki Forest virus isothiazole derivatives against poliovirus type 1
consisting of a monoclonal anti-idiotypic anti- (19) 29
body cross-linked to a protein which contains Pollard, R.B., see Schmitt, D.A. (19) 347
virus-specific T-helper cell epitopes (19) 275
Rankin, J.A., see Beenhouwer, D.O. (19) 43
La Rosa, M.G., see Pinizzotto, M.R. (19) 29 Renau, T.E., Nassiri, M.R., Swayze, E.E., Kern,
Lai, C.M., see Swaminathan, N. (19) 149 E.R., Townsend, L.B., Drach, J.C., Improved
Laub, O., see Almog, Y. (19) 285 synthesis and biological evaluation of an acyclic
Lin, C.-N., see Chang, C.-C. (19) 119 thiosangivamycin active against human cytome-
Lin, J.-Y., see Chang, C.-C. (19) 119 galovirus (19) 15
Liu, S., Wolfe, M.S., Borchardt, R.T., Rational Revello, M.G., see Gerna, G. (19) 333
approaches to the design of antiviral agents Ross, L.J., see Parker, W.B. (19) 325
based on S-adenosyl-L-homocysteine hydrolase Ruprecht, R.M., see Koch, J.A. (19) 81
as a molecular target (19) 247
Lucia, H.L., see Feng, J.S. (19) 193 Santoro, M.G., see Amici, C. (19) 129
Sarasini, A., see Gerna, G. (19) 333
Mansuri, M.M., see Starrett Jr, J.E. (19) 267 Sasaki, H., see Schmitt, D.A. (19) 347
Martin, J.C., see Starrett Jr, J.E. (19) 267 Schalm, S.W., see Berk, L. (19) 111
Mathes, L.E., see Tanabe-Tochikura, A. (19) 161 Schmitt, D.A., Sasaki, H., Pollard, R.B., Suzuki,
Mellors, J.W., see Beenhouwer, D.O. (19) 43 F., Antiviral effects of recombinant human
Miyaichi, Y., see Nagai, T., (19) 207 tumor necrosis factor-alpha in combination
Morrey, J.D., see Warren, R.P. (19) 233 with natural-interferon-beta in mice infected
Morrey, J.D., see Sidwell, R.W. (19) 313 with herpes simplex virus type 1 (19) 347
Secrist III, J.A., see Parker, W.B. (19) 325
Nagai, T., Miyaichi, Y., Tomimori, T., Suzuki, Y., Shaddix, S.C., see Parker, W.B. (19) 325
Yamada, H., In vivo anti-influenza virus Shannon, W.M., see Parker, W.B. (19) 325
activity of plant flavonoids possessing inhibi- Sidwell, R.W., Hitchcock, M., Okleberry, K.M.,
tory activity for influenza virus sialidase (19) Burger, R.A., Warren, R.P., Morrey, J.D.,
207 Suppression of murine retroviral disease by
Nair, V., Ussery, M.A., New hypoxanthine nucleo- 2',3'-didehydro-2’,3’-dideoxythymidine (D4T)
sides with RNA antiviral activity (19) 173 (19) 313
Nassiri, M.R., see Renau, T.E. (19) 15 Sidwell, R.W., see Warren, R.P. (19) 233
Slater, J.D., see Gibson, J.S. (19) 219
Oberg, B., see Olofsson, S. (19) 71 Snijders, A., see Kraaijeveld, C.A. (19) 275
Okleberry, K.M., see Warren, R.P. (19) 233 Snippe, H., see Kraaijeveld, C.A. (19) 275
Okleberry, K.M., see Sidwell, R.W. (19) 313 Sénnerborg, A., see Wondimu, Z. (19) 353
Olofsson, S., Eriksson, S., Karlsson, A., Oberg, B., Starrett Jr, J.E., Tortolani, D.R., Hitchcock,
The HIV replication inhibitor 3’-fluoro-3’- M.J.M., Martin, J.C., Mansuri, M.M., Synth-
deoxythymidine blocks sialylation of N-linked esis and in vitro evaluation of a phosphonate
oligosaccharides (19) 71 prodrug: bis(pivaloyloxymethyl) 9-(2-phospho-
Olsen, R.G., see Tanabe-Tochikura, A. (19) 161 nylmethoxyethyl)adenine (19) 267
Oosterlaken, T.A.M., see Kraaijeveld, C.A. (19) Strannegard, O., see Wondimu, Z. (19) 353
275 Suzuki, Y., see Nagai, T. (19) 207
Suzuki, F., see Schmitt, D.A. (19) 347
Palamara, A.T., see Amici, C. (19) 129 Swaminathan, N., Lai, C.M., Beilharz, M.W.,
Parker, L., see Fisher-Hoch, S.P. (19) 139 Boyer, S.J., Klinken, S.P., Biological activities
Parker, W.B., White, E.L., Shaddix, S.C., Ross, of recombinant murine interferons alpha | and
L.J., Shannon, W.M., Secrist III, J.A., Inter- alpha 4: large difference in antiproliferative
ference with HIV-1 reverse transcriptase-cata- effect (19) 149
lyzed DNA chain elongation by the $5’- Swayze, E.E., see Renau, T.E. (19) 15
triphosphate of the cabocyclic analog of 2’-
deoxyguanosine (19) 325 Tanabe-Tochikura, A., Tochikura, T.S., Blakeslee
Percivalle, E., see Gerna, G. (19) 333 Jr, J.R., Olsen, R.G., Mathes, L.E., Anti-human
Pinizzotto, M.R., Garozzo, A., Guerrera, F., immunodeficiency virus (HIV) agents are also
365
potent and selective inhibitors of feline immu- berry, K.M., Sidwell, R.W., Murine retroviral
nodeficiency virus (FIV)-induced cytopathic disease-enhancing effects of a pyrimidinone
effect: development of a new method for immunomodulator (19) 233
screening of anti-FIV substances in vitro (19) Warren, R.P., see Sidwell, R.W. (19) 313
161 White, E.L., see Parker, W.B. (19) 325
Tochikura, T.S., see Tanabe-Tochikura, A. (19) 161 Whitley, R.J., see Chatterjee, S. (19) 181
Tolman, R.L., see Feng, J.S. (19) 193 Wolfe, M.S., see Liu, S. (19) 247
Tomimori, T., see Nagai, T. (19) 207 Wondimu, Z., Sénnerborg, A., Ayehunie, S.,
Tortolani, D.R., see Starrett Jr, J.E. (19) 267 Britton, S., Strannegard, O., Response of
Townsend, L.B., see Renau, T.E. (19) 15 Ethiopian human immunodeficiency virus type
Tur-Kaspa, R., see Almog, Y. (19) 285 1 isolates to antiviral compounds (19) 353
Ussery, M.A., see Nair, V. (19) 173 Yamada, H., see Nagai, T. (19) 207
Warren, R.P., Morrey, J.D., Burger, R.A., Okle- Zavattoni, M., see Gerna, G. (19) 333
Antiviral Research, 19 (1992) 367-369
Subject Index
(S)-1-[3-hydroxy-2-phosphonyl methoxy) propyl] Antiviral activity; Antiproliferative activity; NK cell
cytosine; Equine herpesvirus-1; Mouse, Foal stimulation; Murine interferon-alpha 1; Murine
(19) 219 interferon-alpha 4 (19) 149
2'-nor-cGMP, DHPG; Cytomegalovirus; Guinea Antiviral activity; Exotic RNA virus; Hypoxanthine
pig; Combined treatment (19) 193 nucleoside (19) 173
2',3'-Didehydro-2’,3'-dideoxythymidine; Friend virus Antiviral agent; Hepatitis B virus; Standardized
complex; Murine retroviral disease (19) 313 assay; Cell culture; Nucleoside analog (19) 55
2',3’-Dideoxyinosine; Interferon; Human immuno- Antiviral effect; Human recombinant TNF-alpha;
deficiency virus; Ethiopia; Africa; 3’-Azido-3’- Natural murine IFN-beta; Synergism (19) 347
deoxythymidine (19) 353 Antiviral therapy; Anti-AIDS therapy; Drug devel-
3'-Azido-3'-deoxythymidine; 2'-3'-Dideoxyinosine; opment; Transgenic mouse; Chimeric mouse;
Interferon; Human immunodeficiency virus; Animal model (19) 81
Ethiopia; Africa (19) 353 Antiviral; Cell fusion; Inhibition; .Feline immuno-
3'-Azido-3'-deoxythymidine; AZT; Zidovudine; deficiency; Virus (19) 161
Mononuclear phagocyte; Monocyte; Macro- AZT; Zidovudine; Mononuclear phagocyte; Mono-
phage; Alveolar macrophage; AIDS; HIV-1 cyte; Macrophage; Alveolar macrophage; AIDS;
(19) 43 HIV-1; 3’-Azido-3’-deoxythymidine (19) 43
3'-Fluoro-3'-deoxythymidine; HIV; Sialylation; Oli-
gosaccharides (19) 71 Biological response modifier; Bropirimine; Pyrimi-
dinone; AIDS; HIV; Friend virus (19) 233
Acquired immunodeficiency syndrome; Human cy- Bropirimine; Biological response modifier; Pyrimi-
tomegalovirus; Immediate-early antigen; Plaque dinone; AIDS; HIV; Friend virus (19) 233
assay; Ganciclovir-resistance (19) 333
Acyclic nucleosides; Ganciclovir; Cellular-DNA Carbocyclic nucleoside; DNA chain terminator;
content; HCMV (19) 15 HIV-1; Reverse transcriptase (19) 325
Africa; 3’-Azido-3’-deoxythymidine; 2’,3’-Dideoxyi- Cell culture; Nucleoside analog; Antiviral agent;
nosine; Interferon; Human immunodeficiency Hepatitis B virus; Standardized assay (19) 55
virus; Ethiopia (19) 353 Cell fusion; Inhibition; Feline immunodeficiency;
AIDS; HIV; Friend virus; Biological response Virus; Antiviral (19) 161
modifier; Bropirimine; Pyrimidinone (19) 233 Cellular-DNA content; HCMV; Acyclic nucleo-
AIDS; HIV-1; 3’-Azido-3’-deoxythymidine; AZT; sides; Ganciclovir (19) 15
Zidovudine; Mononuclear phagocyte; Mono- Chimeric mouse; Animal model; Antiviral therapy;
cyte; Macrophage; Alveolar macrophage (19) 43 Anti-AIDS therapy; Drug development; Trans-
Alveolar macrophage; AIDS; HIV-1; 3’-Azido-3’- genic mouse (19) 81
deoxythymidine; AZT; Zidovudine; Mononuc- Combined treatment; 2'-nor-cGMP, DHPG; Cyto-
lear phagocyte; Monocyte; Macrophage (19) 43 megalovirus; Guinea pig (19) 193
Animal model; Antiviral therapy; Anti-AIDS Cyclopentenone; Heat shock protein; Glycosylation;
therapy; Drug development; Transgenic mouse; Prostaglandin; Sendai virus (19) 129
Chimeric mouse (19) 81 Cytomegalovirus; Guinea pig; Combined treatment;
Anti-AIDS therapy; Drug development; Transgenic 2'-nor-cGMP, DHPG (19) 193
mouse; Chimeric mouse; Animal model; Anti-
viral therapy (19) 81 Dextran sulfate; Influenza; Erythrocyte membrane;
Anti-anti-idiotypic antibody; T-helper epitope; Quil Fusion (19) 295
A; Semliki Forest virus; Vaccine; Monoclonal DNA chain terminator; HIV-1; Reverse transcrip-
anti-idiotypic antibody (19) 275 tase; Carbocyclic nucleoside (19) 325
Antiproliferative activity; NK cell stimulation; DNA polymerase; Hepatitis B virus; Zidovudine
Murine interferon-alpha 1; Murine interferon- (19) 111
alpha 4; Antiviral activity (19) 149 Drug development; Transgenic mouse; Chimeric
Antiviral;Methylation; S-adenosyl-L-homocysteine; mouse; Animal model; Antiviral therapy; Anti-
S-adenosyl-L-homocysteine hydrolase; S-adeno- AIDS therapy (19) 81
sylmetionine (19) 247
368
Enzyme kinetics; Tetrahydroxyxanthone; Reverse (19) 1
transcriptase; ICs (19) 119 HIV; Friend virus; Biological response modifier
Equine herpesvirus-1; Mouse; Foal; (S)-1-[3-hydro- Bropirimine; Pyrimidinone; AIDS (19) 233
xy-2-phosphonyl methoxy) propyl] cytosine (19) HIV; HSV; HCMV; PMEA; Prodrug; Phosphonate
219 transport (19) 267
Erythrocyte membrane; Fusion; Dextran sulfate; HIV; Sialylation; Oligosaccharides; 3’-Fluoro-3’-
Influenza (19) 295 deoxythymidine (19) 71
Estrogen; Hepatitis B virus; Gene expression (19) HIV-1; 3’-Azido-3'-deoxythymidine; AZT; Zidovu-
285 dine; Mononuclear phagocyte; Monocyte; Mac-
Ethiopia; Africa; 3’-Azido-3’-Deoxythymidine; 2’,3’- rophage; Alveolar macrophage; AIDS (19) 43
Dideoxyinosine; Interferon; Human immunode- HIV-1; Reverse transcriptase; Carbocyclic nucleo-
ficiency virus (19) 353 side; DNA chain terminator (19) 325
Exotic RNA virus; Hypoxanthine nucleoside; HPMPC, mechanism of action; Viral replication,
Antiviral activity (19) 173 inhibition of; Herpes simplex Type 1 (19) 181
HSV; HCMV; PMEA; Prodrug; Phosphonate
Feline immunodeficiency; Virus; Antiviral; Cell transport; HIV (19) 267
fusion; Inhibition (19) 161 Human cytomegalovirus; Immediate-early antigen;
Flavonoid; Influenza virus; Sialidase; Neuramini- Plaque assay; Ganciclovir-resistance; Acquired
dase (19) 207 immunodeficiency syndrome (19) 333
Foal; (S)-1-[3-hydroxy-2-phosphonyl methoxy) pro- Human immunodeficiency virus; Ethiopia; Africa;
pyl] cytosine; Equine herpesvirus-1; Mouse (19) 3'-Azido-3'-deoxythymidine; 2’,3’-Dideoxyino-
219 sine; Interferon (19) 353
Friend virus complex; Murine retroviral disease; Human immunodeficiency virus; Nucleoside antivir-
2',3'-Didehydro-2’,3’-dideoxythymidine (19) 313 al; Targeting antiviral; Herpes simplex virus (19)
Friend virus; Biological response modifier Bropir- 1
imine; Pyrimidinone; AIDS, HIV (19) 233 Human recombinant TNF-alpha; Natural murine
Fusion; Dextran sulfate; Influenza; Erythrocyte IFN-beta; Synergism; Antiviral effect (19) 347
membrane (19) 295 Hypoxanthine nucleoside; Antiviral activity; Exotic
RNA virus (19) 173
Ganciclovir; Cellular-DNA content; HCMV; Acyc-
lic nucleosides (19) 15 ICs9; Enzyme kinetics; Tetrahydroxyxanthone;
Ganciclovir-resistance; Acquired immunodeficiency Reverse transcriptase (19) 119
syndrome; Human cytomegalovirus; Immediate- Immediate-early antigen; Plaque assay; Ganciclovir-
early antigen; Plaque assay (19) 333 resistance; Acquired immunodeficiency syn-
Gene expression; Estrogen; Hepatitis B virus (19) drome; Human cytomegalovirus (19) 333
285 Influenza virus; Sialidase; Neuraminidase; Flavo-
Glycosylation; Prostaglandin; Sendai virus; Cyclo- noid (19) 207
pentenone; Heat shock protein (19) 129 Influenza; Erythrocyte membrane; Fusion; Dextran
Guinea pig; Combined treatment; 2’-nor-cGMP, sulfate (19) 295
DHPG; Cytomegalovirus (19) 193 Inhibition; Feline immunodeficiency; Virus; Anti-
viral; Cell fusion (19) 161
HCMYV; Acyclic nucleosides; Ganciclovir; Cellular- Interferon; Human immunodeficiency virus; Ethio-
DNA content (19) 15 pia; Africa; 3’-Azido-3’-deoxythymidine; 2’,3’-
HCMV; PMEA; Prodrug; Phosphonate transport; Dideoxyinosine (19) 353
HIV; HSV (19) 267 Isothiazole derivative; Poliovirus type 1; RNA
Heat shock protein; Glycosylation; Protaglandin; synthesis (19) 29
Sendai virus; Cyclopentenone (19) 129
Hepatitis B virus; Gene expression; Estrogen (19) Lassa fever; Rigor; Side effect; Ribavirin (19) 139
285
Hepatitis B virus; Standardized assay; Cell culture; Macrophage; Alveolar macrophage; AIDS; HIV-1;
Nucleoside analog; Antiviral agent (19) 55 3'-Azido-3’-deoxythymidine; AZT; Zidovudine;
Hepatitis B virus; Zidovudine; DNA polymerase Mononuclear phagocyte; Monocyte (19) 43
(19) 111 Methylation; Antiviral; S-adenosyl-L-homocysteine;
Herpes simplex Type 1; HPMPC, mechanism of S-adenosyl-L-homocysteine hydrolase; S-adeno-
action; Viral replication, inhibition of (19) 181 sylmetionine (19) 247
Herpes simplex virus; Human immunodeficiency Monoclonal anti-idiotypic antibody; Anti-anti-idio-
virus; Nucleoside antiviral; Targeting antiviral typic antibody; T-helper epitope; Quil A; Sem-
369
like Forest virus; Vaccine (19) 275 DNA chain terminator; HIV-1 (19) 325
Monocyte; Macrophage; Alveolar macrophage; Reverse transcriptase; [C5 9;E nzyme kinetics; Tetra-
AIDS; HIV-1; 3’-Azido-3'-deoxythymidine; hydroxyxanthone (19) 119
AZT; Zidovudine; Mononuclear phagocyte (19) Ribavirin; Lassa fever; Rigor; Side effect (19) 139
43 Rigor; Side effect; Ribavirin; Lassa fever (19) 139
Mononuclear phagocyte; Monocyte; Macrophage; RNA synthesis; Isothiazole derivative; Poliovirus
Alveolar macrophage; AIDS; HIV-1; 3’-Azido- type 1 (19) 29
3’-deoxythymidine; AZT; Zidovudine (19) 43
Mouse; Foal; (S)-1-[3-hydroxy-2-phosphonyl meth- S-adenosyl-L-homocysteine; S-adenosyl-L-homocys-
oxy) propyl] cytosine; Equine herpesvirus-1 (19) teine hydrolase; S-adenosylmetionine; Antiviral;
219 Methylation (19) 247
Murine interferon-alpha 1; Murine interferon-alpha S-adenosyl-L-homocysteine hydrolase; Antiviral;
4; Antiviral activity; Antiproliferative activity; Methylation; S-adenosyl-L-homocysteine; S-ade-
NK cell stimulation (19) 149 nosylmetionine (19) 247
Murine interferon-alpha 4; Antiviral activity; Anti- Ss y Antiviral; Methylation; S-
proliferative activity; NK cell stimulation; Mur- adenosyl-L-homocysteine; S-adenosyl-L-homo-
ine interferon-alpha 1 (19) 149 cysteine hydrolase (19) 247
Murine retroviral disease; 2',3’-Didehydro-2’,3’- Semliki Forest virus; Vaccine; Monoclonal anti-
dideoxythymidine; Friend virus complex (19) 313 idiotypic antibody; Anti-anti-idiotypic antibody;
T-helper epitope; Quil A (19) 275
Natural murine IFN-beta; Synergism; Antiviral Sendai virus; Cyclopentenone; Heat shock protein;
effect; Human recombinant TNF-alpha (19) 347 Glycosylation; Prostaglandin (19) 129
Neuraminidase; Flavonoid; Influenza virus; Siali- Sialidase; Neuraminidase; Flavonoid; Influenza
dase (19) 207 virus (19) 207
NK cell stimulation; Murine interferon-alpha 1; Sialylation; Oligosaccharides; 3’-Fluoro-3'-deoxy-
Murine interferon-alpha 4; Antiviral activity; thymidine; HIV (19) 71
Antiproliferative activity (19) 149 Side effect; Ribavirin; Lassa fever; Rigor (19) 139
Nucleoside analog; Antiviral agent; Hepatitis B Standardized assay; Cell culture; Nucleoside ana-
virus; Standardized assay; Cell culture (19) 55 log; Antiviral agent; Hepatitis B virus (19) 55
Nucleoside antiviral; Targeting antiviral; Herpes Synergism; Antiviral effect; Human recombinant
simplex virus; Human immunodeficiency virus TNF-alpha; Natural murine IFN-beta (19) 347
(19) 1
T-helper epitope; Quil A; Semliki Forest virus;
Oligosaccharides; 3'-Fluoro-3’-deoxythymidine; Vaccine; Monoclonal anti-idiotypic antibody;
HIV; Sialylation (19) 71 Anti-anti-idiotypic antibody (19) 275
Targeting antiviral; Herpes simplex virus; Human
Phosphonate transport; HIV; HSV; HCMV; immunodeficiency virus; Nucleoside antiviral
PMEA,; Prodrug (19) 267 (19) 1
Plaque assay; Ganciclovir-resistance; Acquired Tetrahydroxyxanthone; Reverse transcriptase; ICspo;
immunodeficiency syndrome; Human cytomega- Enzyme kinetics (19) 119
lovirus; Immediate-early antigen (19) 333 Transgenic mouse; Chimeric mouse; Animal model;
PMEA; Prodrug; Phosphonate transport; HIV; Antiviral therapy; Anti-AIDS therapy; Drug
HSV; HCMV (19) 267 development (19) 81
Poliovirus type 1; RNA synthesis; Isothiazole
derivative (19) 29 Vaccine; Monoclonal anti-idiotypic antibody; Anti-
Prodrug; Phosphonate transport; HIV; HSV; anti-idiotypic antibody; T-helper epitope; Quil
HCMV; PMEA (19) 267 A; Semliki Forest virus (19) 275
Prostaglandin; Sendai virus; Cyclopentenone; Heat Viral replication, inhibition of; Herpes simplex Type
shock protein; Glycosylation (19) 129 1; HPMPC, mechanism of action (19) 181
Pyrimidinone; AIDS; HIV; Friend virus; Biological Virus; Antiviral; Cell fusion; Inhibition; Feline
response modifier Bropirimine (19) 233 immunodeficiency (19) 161
Quil A; Semliki Forest virus; Vaccine; Monoclonal Zidovudine; DNA polymerase; Hepatitis B virus
anti-idiotypic antibody; Anti-anti-idiotypic anti- (19) 111
body; T-helper epitope (19) 275 Zidovudine; Mononuclear phagocyte; Monocyte;
Macrophage; Alveolar macrophage; AIDS,
Reverse transcriptase; Carbocyclic nucleoside; HIV-1; 3’-Azido-3’-deoxythymidine; AZT (19) 43
